The general focus of my scientific career is to identify and characterize protective and pathogenic CD4+ T cell responses and define the “rules” that govern their generation and stability. In the laboratory where I did my Ph.D. we demonstrated that microbial antigen-specific CD4+ T cells can be activated by self-antigen that is expressed in the target organ (cross-reactive T cells) in experimental arthritis. This confirmed the old paradigm of molecular mimicry but we expanded this by a) showing that the self-antigen was recognized as an altered T cell epitope b) thereby eliciting a protective T cell response by T cell expression of the costimulatory molecule B7.2 and IL-10 production c) demonstrating that administration of similar T cell epitopes through the nasal route, a potential clinical application, was protective in experimental arthritis. On a similar note I identified T cell epitopes of cytomegalovirus that activated brain-antigen specific CD4+ and CD8+ T cells that could potentially be involved in the pathogenesis of a non-human primate model of multiple sclerosis. Lastly I contributed to research that refuted the old concept that is still in current immunology textbooks namely, that antigens from the testes are excluded from exposure to the immune system due to testicular immune privilege. We have shown that a) some testicular antigens are not sequestered b) induce active tolerance c) that involves activation of regulatory T cells. In additional studies I showed that a) both testicular-antigen specific regulatory and effector CD4+ T cells are enriched and activated in the testes of mice with autoimmune orchitis, b) their activation is initiated by and localized to the site of testis-antigen immune-complex deposition, c) the phenotype and function of T cells in the target organ change during autoimmune disease progression where regulatory T cells start to secrete effector cytokines and effector T cells become resistant to suppression. This included development of an in vitro micro-assay to do functional analysis of T cells isolated from the target organ. Currently I am involved in research focused on identifying and characterizing rhinovirus-specific CD4+ T cell responses and their dynamics (subtypes, function, effector/memory) in a human experimental rhinovirus challenge model by applying state-of-the-art technologies, such as mass cytometry (CyTOF) and single-cell gene expression profiling.
Allergy Asthma Autoimmune Diseases effector T cells Follicular helper T cells Immune tolerance Immunology and allergy Immunology / Biochemistry Regulatory T cells T cell biology Virus specific T cells
Editorial Board Memberships
Alberta is not currently contributing as an editor for any journal or publisher.
Has reviewed for
Pre Publication Reviews
Your statistics are calculated based on the information you have submitted to Publons.
Read more about them here.
Compare your statistics to those of any research field on Publons using the form below. Leaving the form blank will compare your statistics to all research fields on Publons.
Reviews (last 12 months)
Reviews (average per year)
Journal Impact Factors of journals reviewed for
The distribution of the Journal Impact Factors of journals Alberta Paul has reviewed for.
All fields reviewers
Total reviews over time
A cumulative record of Alberta Paul's total number of reviews.
Reviews per month
The total number of reviews performed by Alberta Paul each month.
Average review length
The average number of words per review compared to the average of All fields reviewers and the average of reviewers at affiliated institutions.
Note: only reviews with associated content are included in the graph below and where content is present we can not guarantee that it is complete or truly the content of the review.
Weekly review punchcard
The distribution of days that reviews were performed on, compared to All fields reviewers and reviewers at affiliated institutions.